We are live on ! Find out more
Charles Schwab

Charles Schwab Portfolio holdings

AUM $654B
1-Year Est. Return 26.35%
 

Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.

This Fund
S&P 500
This Quarter Est. Return
+10.8%
1 Year Est. Return
+26.35%
3 Year Est. Return
+83.88%
5 Year Est. Return
+111.55%
10 Year Est. Return
+435.01%
AUM
$433B
AUM Growth
+$39.3B
Cap. Flow
+$6.99B
Cap. Flow %
1.61%
Top 10 Hldgs %
19.86%
Holding
3,573
New
35
Increased
2,384
Reduced
635
Closed
102

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$2.16B
2
HSY icon
Hershey
HSY
+$663M
3
LMT icon
Lockheed Martin
LMT
+$622M
4
MO icon
Altria Group
MO
+$525M
5
PFE icon
Pfizer
PFE
+$499M

Top Sells

Rank Stock Value
1
AVGO icon
Broadcom
AVGO
+$2.76B
2
MRK icon
Merck
MRK
+$2.35B
3
ADP icon
Automatic Data Processing
ADP
+$1.57B
4
BX icon
Blackstone
BX
+$1.38B
5
ITW icon
Illinois Tool Works
ITW
+$1.13B

Sector Composition

Rank Sector Weight
1 Technology 22.85%
2 Financials 12.71%
3 Healthcare 11.72%
4 Consumer Discretionary 10.09%
5 Industrials 9.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RCAT icon
3451
Red Cat Holdings
RCAT
$1.15B
$14.1K ﹤0.01%
18,398
STRM
3452
DELISTED
Streamline Health Solutions
STRM
$13.9K ﹤0.01%
1,935
OPTT icon
3453
Ocean Power Technologies
OPTT
$48.9M
$12.9K ﹤0.01%
48,625
XLO icon
3454
Xilio Therapeutics
XLO
$59.9M
$12.9K ﹤0.01%
852
DMRA
3455
Damora Therapeutics, Inc. Ordinary Shares
DMRA
$1.78B
$12.3K ﹤0.01%
630
SPRB
3456
Spruce Biosciences
SPRB
$118M
$12K ﹤0.01%
204
QNCX icon
3457
Quince Therapeutics
QNCX
$22.9M
$11.7K ﹤0.01%
55
VNRX icon
3458
VolitionRx Ltd
VNRX
$8.65M
$11.6K ﹤0.01%
769
RJET
3459
Republic Airways Holdings
RJET
$967M
$11.3K ﹤0.01%
859
CLNN icon
3460
Clene
CLNN
$64.1M
$10.9K ﹤0.01%
1,285
VWE
3461
DELISTED
Vintage Wine Estates, Inc. Common Stock
VWE
$10.6K ﹤0.01%
29,567
QUBT icon
3462
Quantum Computing Inc
QUBT
$1.83B
$10.1K ﹤0.01%
10,216
SBEV icon
3463
Splash Beverage Group
SBEV
$2.33M
$9.37K ﹤0.01%
127
CTM icon
3464
Castellum
CTM
$68M
$8.93K ﹤0.01%
34,318
BNED icon
3465
Barnes & Noble Education
BNED
$431M
$8.61K ﹤0.01%
119
SDOT icon
3466
Sadot Group
SDOT
$14M
$8.29K ﹤0.01%
14
DMTK
3467
DELISTED
DermTech, Inc. Common Stock
DMTK
$8.08K ﹤0.01%
11,512
WKSP icon
3468
Worksport
WKSP
$9.71M
$8.01K ﹤0.01%
1,392
TOVX icon
3469
Theriva Biologics
TOVX
$9.64M
$6.36K ﹤0.01%
543
MRDB
3470
DELISTED
MariaDB plc
MRDB
$6.23K ﹤0.01%
13,835
FFAI
3471
Faraday Future Intelligent Electric
FFAI
$15.2M
$2.73K ﹤0.01%
5
+1
+25% +$1.76K
AQMS icon
3472
Aqua Metals
AQMS
$8.99M
-118
Closed -$18K
ASMB icon
3473
Assembly Biosciences
ASMB
$498M
-2,704
Closed -$26.6K
ATER icon
3474
Aterian
ATER
$4.45M
-3,272
Closed -$13.7K
BENF icon
3475
Beneficient
BENF
$46.4M
-59
Closed -$18.4K

Similar funds

Charles Schwab's Q1 2024 Portfolio in Review

As of Q1 2024, Charles Schwab held 3,573 positions worth $433B, up 10% from $394B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Trading was light in Q1 2024: portfolio turnover was 3.8%. Charles Schwab opened 35 new positions and exited 102, leaving the 3,573-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 23% a quarter earlier, followed by Financials and Healthcare.

  • Charles Schwab's largest Q1 2024 buy was Schwab Fundamental US Large Company Index ETF: 3,608,604 shares worth $81.1M.
  • Charles Schwab added most to Bristol-Myers Squibb in Q1 2024, an estimated $2.16B increase.
  • Charles Schwab's biggest Q1 2024 reduction was Broadcom, cutting an estimated $2.76B.
  • Charles Schwab fully exited Splunk Inc in Q1 2024, selling an estimated $104M.
  • Charles Schwab's ten largest holdings make up 20% of its $433B portfolio in Q1 2024.
  • Charles Schwab opened 35 new positions and closed 102 in Q1 2024.
  • Charles Schwab's portfolio value rose 10% quarter-over-quarter to $433B.

Based on Charles Schwab's 13F filing for Q1 2024, filed 9 May 2024.